Détails du rapport Vaer
Âge: N/A
Genre: Male
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
Fabricant: PFIZER
Lot: fh9951
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2021-10-26
- Date d’apparition
- 1
- Nombre de jours (date d’apparition – date de vaccination)
- 1
- Description de l’événement indésirable
-
hospitalization for transient ischemic attack. 4 days after the administration of the vaccine dose (after sars-cov-2 infection, which occurred previously, with hospitalization, for 14 days.; fever; headache; myalgia; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority-web. regulatory number: it-minisal02-842738. a 43 year-old male patient received bnt162b2 (comirnaty), intramuscular, administered in arm right, administration date 26oct2021 (lot number: fh9951) as dose 1,single for covid-19 immunisation. relevant medical history included: "covid 19", start date: may2021 (unknown if ongoing), notes: for which he was hospitalized from 12may2021 to 26may2021; "bronchial asthma" (unknown if ongoing); "anxiety" (unspecified if ongoing). concomitant medication(s) included: xanax taken for anxiety. the following information was reported: transient ischaemic attack (hospitalization, life threatening) with onset 27oct2021, outcome "not recovered", described as "hospitalization for transient ischemic attack. 4 days after the administration of the vaccine dose (after sars-cov-2 infection, which occurred previously, with hospitalization, for 14 days."; pyrexia (life threatening) with onset 27oct2021, outcome "not recovered", described as "fever"; headache (life threatening) with onset 27oct2021, outcome "not recovered", described as "headache"; myalgia (life threatening) with onset 27oct2021, outcome "not recovered", described as "myalgia". the patient was hospitalized for transient ischaemic attack (start date: 30oct2021, discharge date: 31oct2021, hospitalization duration: 1 day(s)). therapeutic measures were taken as a result of transient ischaemic attack. additional information: actions taken (currently undergoing anticoagulant therapy since the day of admission for ra) - impact on quality of life (10/10). start date of therapy for ra (cardioaspirin 100 mg tablets since 30oct2021 to date). patient was admitted to the hospital since 30oct2021 to 31oct2021. reporter comment: patient suffering from bronchial asthma, about to make further visits to confirm what was already highlighted by the national health service years ago and to be treated again for this pathology. no follow-up attempts are completed. no further information is expected.; reporter's comments: patient suffering from bronchial asthma, about to make further visits to confirm what was already highlighted by the national health service years ago and to be treated again for this pathology
- Données de laboratoire
-
na
- Liste des symptômes
-
headache pyrexia myalgia transient ischaemic attack
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Oui
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na